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The spastic velocity threshold predicts botulinum toxin-a treatment outcome in the medial 
hamstrings of children with cerebral palsy. 
Introduction  
Data collected using an innovative instrumented spasticity assessment (ISA) in the medial hamstrings 
(MEH) of children with cerebral palsy (CP) shows large variability among subjects in the velocity 
threshold (VT) at which hyperreflexia (spasticity) occurs. Intramuscularly injected Botulinum toxin-A 
(BTX) is effective in temporarily decreasing spasticity in the MEH, although a large variability in 
response is reported. 
Purpose 
To investigate whether the spastic VT pre-treatment can predict the effect of BTX in the MEH of 
children with CP. 
Method 
Forteen children with CP (10±2yrs) were measured pre- and post-BTX with 3D gait analysis (3DGA) 
and ISA. From 3DGA, improvement in knee extension during terminal swing (Kneepost) was 
analysed. During ISA, kinematics and electromyography (EMG) were recorded during slow and fast 
passive MEH stretches. Average normalized root mean square EMG was calculated pre-BTX during 
slow stretch (pre rms-EMGslow) and post-BTX as the change between slow and fast (rms-EMGpost). 
Muscles with high rms-EMGslow values pre-BTX were categorized as low-VT, those with low rms-
EMGslow values, as high-VT. Rms-EMGpost and Kneepost were statistically compared between low-VT 
and high-VT muscles. The relationships between pre rms-EMGslow with rms-EMGpost and with 
Kneepost were investigated using Spearman correlations (significance p<0.05). 
Results 
Rms-EMGpost was lower (p=0.01) in those muscles categorised pre-BTX as high-VT. There were 
significant negative correlations for pre rms-EMGslow with rms-EMGpost (r=-0.63) and with Kneepost (r=-
0.48) indicating that muscles with low-VT are less likely to respond to BTX, as assessed both 
passively and during gait. 
Discussion and Conclusions 
Assessment of the spastic threshold in the MEH in children with CP can be used to choose the most 
effective treatment for the individual patient. The etiology behind the different spastic thresholds 
requires further investigation. 
 
